New Official Recommendations Say Take Aspirin* - By Dr. Calvin Day**

SAN ANTONIO - Sept. 16, 2015 - PRLog -- For the first time ever (apparently), a major American medical organization has issued a broad recommendation to take aspirin to prevent a form of cancer. Aspirin if taken for at least 10 years appears to lower the risk of developing colon cancer. It may also reduce the risk of developing esophageal cancer, stomach cancer, and possibly breast cancer, prostate cancer, and lung cancer as well. As a result of an accumulating body pf evidence of the benefits of aspirin in cancer prevention as well its generally accepted protective effect in reducing cardiovascular disease, the US Preventive Services Task Force (USPSTF) yesterday drafted a proposal recommending a daily low-dose aspirin for *adults ages 50 to 69 expected to live at least 10 years, and who are at a 10 percent or greater risk of heart attack or stroke during that time. Although the benefits of low dose aspirin ingestion appear to outweigh the risks in certain subgroups who have an elevated risk of heart disease or stroke, it is important to not start aspirin therapy on your own but rather to consult with your doctor first, because serious side effects of aspirin include gastrointestinal (GI) bleeding and hemorrhagic stroke.

**DR. CALVIN DAY -- PROFESSIONAL BIOGRAPHICAL SUMMARY

·         Dr. Calvin Day is a self-employed medical writer and non-clinical consultant on dermatology, general medical, and general health issues.

·         Dr. Day graduated summa cum laude from Texas A&M University (College Station), and

·         Was the Salutatorian (second academically ranked student) of his 1976 medical school graduating class at the University of Texas Southwestern Medical School in Dallas.

·         Following graduation from medical school, Dr. Day trained for an additional six years in the Harvard Medical School programs at Massachusetts General Hospital

         o   in Internal Medicine,

         o   Dermatology, and

         o   Dermatopathology.

·         Dr. Day completed his last and seventh year of formal post medical school training as a Mohs Surgery Fellow under the tutelage of Dr. Perry Robins who officed at New York University Medical Center.

·         Dr. Day was the principal author of more than 60 professional articles published in refereed medical journals, including two publications in the New England Journal of Medicine. The majority of these articles dealt with skin cancer with a focus on malignant melanoma.

·         Following his formal medical training, Dr. Day, for 28 years had a private practice in San Antonio wherein he routinely logged more than 90 hours per week while building a thriving practice  consisting of  approximately 40,000 patients who, by in large, had skin cancer and cosmetic dermatology concerns.

·          During this same 28 year period, Dr. Day devoted a portion of his time to teaching skin surgery to dermatology residents at The University of Texas Health Science Center at San Antonio (UTHSCSA), where he held an appointment as “Clinical Professor of Medicine (Dermatology)”.

·          In 2010, Dr. Day was honored by having a UTHSCSA dermatology professorship named after him after he declined a personal gift of $100,000 and diverted it instead to the Dermatology Program at UTHSCSA.

·         From March 2009 through April 2011, Dr. Day made 126 donations to 97 different charitable organizations through charity golf tournaments.

·         For seven consecutive years, from 2004 through 2010 Dr. Day was selected by Texas Monthly as one of Texas’ “Superdoctors”, and

·          In 2010, he was also designated by Newsweek magazine as one of the “Best Doctors in Texas”.